Dr. Elizabeth A. Poplin, MD

  • New Brunswick, NJ
  • Medical oncologist
NPI1073698767
Medicare services, 2022
197
Part D claims, 2022
11
Publications
19
Clinical trials
4
Industry payments
$23
Practice address
1 Robert Wood Johnson Pl, New Brunswick, NJ 08901
Practice phone
Call (732) 235-7840
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Poplin's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Elizabeth A. Poplin is a medical oncologist in New Brunswick, New Jersey

Dr. Poplin practices in New Brunswick, New Jersey.

Dr. Poplin's NPI, 1073698767, was assigned on October 25, 2006. Dr. Poplin holds New Jersey license 25MA06496300.

NPI and contact details
NPI enumeration date
October 25, 2006
NPI status
Active
Practice phone
(732) 235-7840
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female

Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data

Dr. Elizabeth A. Poplin's practice address is in New Brunswick, New Jersey

Dr. Poplin's practice address in the NPI Registry is 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901, in Middlesex County. The practice phone is (732) 235-7840.

  • NPI Registry address
    1 Robert Wood Johnson Pl, New Brunswick, NJ 08901 · Middlesex CountyPhone(732) 235-7840

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dmand AI tracks the EHR system at Dr. Elizabeth A. Poplin's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Poplin practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dr. Poplin's practiceAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Poplin practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Elizabeth A. Poplin is one of 115 medical oncologists in New Jersey

Medical oncology is Dr. Poplin's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Poplin is licensed in New Jersey.

Specialties and state licenses

  • Medical oncology, New JerseyPrimaryLicense 25MA06496300 · taxonomy 207RX0202X

Medical oncologists near Dr. Poplin

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Elizabeth A. Poplin billed Medicare for 197 services in 2022

CMS data shows 197 Medicare services from Dr. Poplin across 4 procedure codes in 2022. Medicare paid $19,535 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2022197
Paid by Medicare$19,535
Procedure codes4

Dr. Poplin's Medicare services by type, 2021 to 2022

  • 2021
  • 2022
Office and hospital visits
2021: 5672022: 19765%

Dr. Poplin compared with the New Jersey median for medical oncologists, 2022

  • Dr. Poplin
  • New Jersey median
Medicare services
197vs 72373% below
Part D claims
11vs 35997% below

Medians across 107 medical oncologists in New Jersey with Dmand AI profiles that report each measure.

Dr. Poplin's most billed Medicare procedure codes, 2022

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Poplin

Need commercial claims for Dr. Poplin?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Poplin and other medical oncologists in New Jersey.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Elizabeth A. Poplin wrote 11 Medicare Part D claims in 2022

In 2022, Dr. Poplin wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $543 in total drug cost. In 2021, CMS named 14 claims across 1 drug.

Part D claims, 202211
Drugs named by CMS1
Total drug cost$543

Dr. Poplin's most prescribed drugs by claims, 2022

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2021 to 2022

  • 2021
  • 2022
Claims for drugs CMS names
2021: 142022: 1121%

Drugs named by CMS: 1 in 2022, 1 in 2021.

See all prescribing by Dr. Poplin

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Poplin by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Elizabeth A. Poplin has 19 publications on record

Dmand AI links 19 papers to Dr. Poplin, published from 2011 to 2020. 2012 was the busiest year, with 4. The most frequent topics are Maximum Tolerated Dose. Dr. Poplin has published most often in JCO Precis Oncol. Dr. Poplin's most frequent co-authors are Janice M. Mehnert, Salma K. Jabbour and Usha Malhotra, MD.

Papers19
Years published2011 to 2020

Dr. Poplin's papers by year, 2011 to 2020

Topics Dr. Poplin writes about most

  • Maximum Tolerated Dose

Dr. Poplin's most frequent co-authors

Recent publications by Dr. Poplin

See all 19 publications and co-authors

See who Dr. Poplin researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Poplin works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Elizabeth A. Poplin has worked on 4 clinical trials

Dmand AI links Dr. Poplin to 4 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Neoplasm Metastasis, Somatostatinoma and Carcinoma, Islet Cell. National Cancer Institute (NCI) sponsors the most, 2.

Clinical trials with Dr. Poplin by phase

  1. 2Phase 1: 2 trials
  2. 2Phase 2: 2 trials
  3. NonePhase 3: no trials
  4. NonePhase 4: no trials

Conditions in Dr. Poplin's trials

  • Neoplasm Metastasis
  • Somatostatinoma
  • Carcinoma, Islet Cell
  • Neoplastic Processes

Investigators on the most trials with Dr. Poplin

Recent clinical trials with Dr. Poplin

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Elizabeth A. Poplin received $23 in industry payments in 2018

CMS Open Payments shows 2 general payments to Dr. Poplin from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Spectrum Pharmaceuticals Inc. paid the most, $23.

Companies that paid Dr. Poplin the most, 2018 to 2018

Share is of all general payments to this clinician.

See all payments to Dr. Poplin

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Elizabeth A. Poplin's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Elizabeth A. Poplin

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Elizabeth A. Poplin's NPI number?

Dr. Elizabeth A. Poplin's NPI number is 1073698767. It was assigned on October 25, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Elizabeth A. Poplin?

Dr. Elizabeth A. Poplin is a medical oncologist in New Brunswick, New Jersey. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Elizabeth A. Poplin practice?

Dr. Poplin practices at 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901.

What is Dr. Elizabeth A. Poplin's office phone number?

The practice phone on file for Dr. Poplin is (732) 235-7840.

What is Dr. Elizabeth A. Poplin's medical license number?

Dr. Poplin holds New Jersey license 25MA06496300.

Does Dr. Elizabeth A. Poplin accept Medicare?

Yes. CMS data shows Dr. Poplin billed Medicare for 197 services in 2022.

What services does Dr. Elizabeth A. Poplin bill to Medicare?

In 2022, Dr. Poplin's most billed Medicare services were hospital inpatient care (99233), hospital inpatient care (99223) and hospital inpatient care (99232).

What drugs does Dr. Elizabeth A. Poplin prescribe most?

In 2022 Medicare Part D data, Dr. Poplin's most prescribed drugs by claims were Oxycodone HCl.

Has Dr. Elizabeth A. Poplin received payments from drug or device companies?

CMS Open Payments shows $23 in general payments to Dr. Poplin from 1 company from 2018 to 2018. The largest total came from Spectrum Pharmaceuticals Inc.

How long has Dr. Elizabeth A. Poplin been practicing?

Dr. Poplin's NPI was assigned in 2006.

Does Dr. Elizabeth A. Poplin do research?

Dmand AI links 19 publications to Dr. Poplin, published from 2011 to 2020. Dr. Poplin has worked on 4 clinical trials.

Who does Dr. Elizabeth A. Poplin publish with?

Dr. Poplin's most frequent co-authors are Janice M. Mehnert (4 shared papers), Salma K. Jabbour (3 shared papers) and Usha Malhotra, MD (3 shared papers).

Selling to medical oncology practices?

See medical oncologists in New Jersey by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)